BPG is committed to discovery and dissemination of knowledge
Articles in Press
12/25/2025 6:50:02 AM | Browse: 2 | Download: 0
Publication Name World Journal of Diabetes
Manuscript ID 113149
Country India
Category Endocrinology & Metabolism
Manuscript Type Review
Article Title Metabolic dysfunction-associated steatotic liver disease and type 2 diabetes: Pathophysiology, diagnosis, and emerging therapeutic strategies
Manuscript Source Invited Manuscript
All Author List Mithil Gowda Suresh, Safia Mohamed, Harinivaas S Geetha, Sushmita Prabhu, Nitin Trivedi, Zhu C Ng, Priyal D Mehta, Ajit S Brar, Aalam Sohal, Manjeet K Goyal, Juniali Hatwal and Akash Batta
Funding Agency and Grant Number
Corresponding Author Akash Batta, Department of Cardiology, Dayanand Medical College and Hospital, Tagore Nagar, Civil Lines, Ludhiana 141001, Punjab, India. akashbatta02@gmail.com
Key Words Metabolic dysfunction-associated steatotic liver disease; Type 2 diabetes mellitus; Insulin resistance; Hepatic fibrosis; Non-invasive diagnostics; Glucagon-like peptide-1 receptor agonists; Sodium-glucose cotransporter-2 inhibitors; Personalized medicine; Fatty liver; Metabolic associated steatohepatitis
Core Tip Metabolic dysfunction-associated steatotic liver disease is highly prevalent among patients with type 2 diabetes mellitus, amplifying risks of fibrosis, cirrhosis, hepatocellular carcinoma, and cardiovascular disease. The pathogenesis reflects overlapping mechanisms of insulin resistance, dyslipidemia, inflammation, and genetic predisposition. This narrative review integrates updated evidence on epidemiology, diagnostics, and therapeutics, emphasizing the roles of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors, and emerging agents. A multidisciplinary, personalized approach remains essential to reduce the burden of this increasingly recognized disease spectrum.
Citation Suresh MG, Mohamed S, Geetha HS, Prabhu S, Trivedi N, Ng ZC, Mehta PD, Brar AS, Sohal A, Goyal MK, Hatwal J, Batta A. Metabolic dysfunction-associated steatotic liver disease and type 2 diabetes: Pathophysiology, diagnosis, and emerging therapeutic strategies. World J Diabetes 2025; In press
Received
2025-08-18 01:04
Peer-Review Started
2025-08-18 02:07
First Decision by Editorial Office Director
2025-09-03 03:12
Return for Revision
2025-09-03 03:12
Revised
2025-09-14 14:13
Publication Fee Transferred
Second Decision by Editor
2025-11-14 02:44
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2025-12-25 06:50
Articles in Press
2025-12-25 06:50
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-9358 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com